Growth and differentiation factor 15: An emerging therapeutic target for brain diseases
BioScience Trends · 28.02.2025 · 19 (1) · 72-86
DOI: 10.5582/bst.2024.01305 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioScience Trends, erschienen am 28.02.2025. Verfasst von Yingying Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Brain Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 119 Literaturangaben.
Abstract (Originalsprache)
Growth and differentiation factor 15 (GDF15), a member of the transforming growth factor-βsuperfamily, is considered a stress response factor and has garnered increasing attention in recent years due to its roles in neurological diseases. Although many studies have suggested that GDF15 expression is elevated in patients with neurodegenerative diseases (NDDs), glioma, and ischemic stroke, the effects of increased GDF15 expression and the potential underlying mechanisms remain unclear. Notably, many experimental studies have shown the multidimensional beneficial effects of GDF15 on NDDs, and GDF15 overexpression is able to rescue NDD-associated pathological changes and phenotypes. In glioma, GDF15 exerts opposite effects, it is both protumorigenic and antitumorigenic. The causes of these conflicting findings are not comprehensively clear, but inhibiting GDF15 is helpful for suppressing tumor progression. GDF15 is also regarded as a biomarker of poor clinical outcomes in ischemic stroke patients, and targeting GDF15 may help prevent this disease. Thus, we systematically reviewed the synthesis, transcriptional regulation, and biological functions of GDF15 and its related signaling pathways within the brain. Furthermore, we explored the potential of GDF15 as a therapeutic target and assessed its clinical applicability in interventions for brain diseases. By integrating the latest research findings, this study provides new insights into the future treatment of neurological diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Medical Genetics, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Zitieren
APA
Zhou, Y., Dou, L., Wang, L., Chen, J., Mao, R., Zhu, L., Liu, D., & Zheng, K. (2025). Growth and differentiation factor 15: An emerging therapeutic target for brain diseases. BioScience Trends, 19(1), 72-86. https://doi.org/10.5582/bst.2024.01305
Vancouver
Zhou Y, Dou L, Wang L, Chen J, Mao R, Zhu L, et al. Growth and differentiation factor 15: An emerging therapeutic target for brain diseases. BioScience Trends. 2025;19(1):72-86. doi:10.5582/bst.2024.01305
BibTeX
@article{Zhou2025,
author = {Zhou, Yingying and Dou, Lei and Wang, Luyao and Chen, Jiajie and Mao, Ruxue and Zhu, Lingqiang and Liu, Dan and Zheng, Kai},
title = {Growth and differentiation factor 15: An emerging therapeutic target for brain diseases},
journal = {BioScience Trends},
year = {2025},
volume = {19},
number = {1},
pages = {72--86},
doi = {10.5582/bst.2024.01305}
}
EUVIMED